Stabilized liposome/amphotercin B composition and method
AssigneeLiposome Technology, Inc.
InventorsRobert Abra, Francis C. Szoka
Life of this patent
Estimating the term…
Abstract
A method of administering a liposome/amphotericin B composition having a predetermined size distribution in 0.2-0.5 micron size range. The method includes preparing a suspension of heterogeneously sized amphotericin B liposomes in an aqueous solution containing at least about 0.5% w/v of membrane-stabilizing agent. After sizing to the desired size distribution, and before the liposome sizes change substantially, the suspension is lyophilized for storage. After reconstituting the lyophilized material, the resulting suspension is administered before a substantial size changes in the liposomes occur.
Claims1
A method of administering liposomes containing amphotericin B and having, after a storage period, a selected liposome size distribution in a size range of 0.5 microns or less, comprising:
- preparing a suspension of heterogeneously sized lipsomes containign amphotericin B in the lipid phase and, in the aqueous phase, at least about 0.5% w/v of a membrane-stabilizing agent,
- reducing the size heterogeneity of the liposome suspension to achieve said selected liposome size distribution,
- lyophilizing the liposome suspension before the size distribution of the liposomes changes substantially,
- after such storage period, adding an aqueous medium to the lyophilized suspension, said adding being effective to produce a reconstituted suspension of liposomes in which the size distribution achieved by said reducing is substantially preserved, and
- administering the reconstituted liposomes before the size distribution of the liposomes changes substantially.
Dependencies are inferred from the claim text.